In addition, both knockdown of and key mutations in DHCR7 suppressed malignant phenotypes of GC cells through inhibiting cholesterol biosynthesis, which indicated that intervention with the cholesterol synthesis pathway is also a potential treatment strategy for GC. The gene discussed is DHCR7; the disease is gastric cancer.